Skip to main content

The Law Offices of Frank R. Cruz Announces Investigation of Tellurian Inc. (TELL) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Tellurian Inc. (“Tellurian ” or the “Company”) (NYSE: TELL) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On January 20, 2022, Tellurian’s Chief Executive Officer (“CEO”), Charif Souki, was sued by Christopher Parker, who invested tens of millions of dollars in the Company. When Parker sought to sell his shares in mid-2019, Souki allegedly induced him to delay selling Tellurian shares by offering to indemnify Parker against any losses through the end of 2020. This agreement was memorialized by text messages. When Parker sought a written agreement extending the term to December 31, 2021 and providing for interest, Souki allegedly agreed to the terms but refused to sign the agreement because Souki omitted the liability in his disclosures to his lenders.

On this news, Tellurians’ stock price fell $0.17, or 6%, to close at $2.65 per share on January 21, 2022.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Tellurian securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.